Observation Study of the Clinical Management of Bipolar Disorder

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Bipolar Disorder

Study type

Observational

Funder types

Industry

Identifiers

NCT01770704
NIS-NCN-XXX-2012/1

Details and patient eligibility

About

The objective of the ambispective cohort study is to describe clinical management and clinical outcomes related to bipolar disorder in China, and establish the factors associated with different management patterns and clinical outcomes, provide psychiatrists with reliable and up-to-date information on the disease.

Enrollment

520 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Provision of subject informed consent.
  • Diagnosis of Bipolar Disorder I or II (DSM-IV TR) in any phase of the disorder.
  • Patients who had at least one mood event( depression, mania, hypomania or mixed) according to DSM-IV TR definition during the 3 and 12 months prior to the beginning of the study.

Exclusion criteria

  • Inability to complete Patient Reported Outcomes (PROs) questionnaires.
  • Participation in an interventional clinical study in last 12 months.

Trial design

520 participants in 1 patient group

Patients diagnosed with bipolar disorder I or II

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems